Factors effecting platelet activation in children with poorly controlled type 1 diabetes mellşitus
| dc.contributor.author | Swartz, Jonathan M. | |
| dc.contributor.author | Akıncı, Ayşehan | |
| dc.contributor.author | Andrew, Shayne F. | |
| dc.contributor.author | Sığırcı, Ahmet | |
| dc.contributor.author | Andrew, Shayne F. | |
| dc.contributor.author | Hirschhorn, Joel N | |
| dc.contributor.author | Rosenfeld, Ron G. | |
| dc.contributor.author | Dauber, Andrew | |
| dc.contributor.author | Hwa, Vivian | |
| dc.date.accessioned | 2017-07-09T13:50:19Z | |
| dc.date.available | 2017-07-09T13:50:19Z | |
| dc.date.issued | 2013 | |
| dc.department | İnönü Üniversitesi | en_US |
| dc.description | HealthMED | en_US |
| dc.description.abstract | Background—Cockayne syndrome is an autosomal recessive, heterogeneous syndrome with classic features, including short stature, microcephaly, developmental delay, neuropathy, and photosensitivity. New genomic approaches offer improved molecular diagnostic potential. Methods—Whole-exome sequencing was employed to study a consanguineous extended family with severe short stature and variable presentations of peripheral neuropathy, lipoatrophy, photosensitivity, webbed neck, and hirsutism. Results—We identified a novel homozygous ERCC6 variant at the donor splice site of intron 9 (c.1992+3A>G), which was predicted to only slightly perturb splicing efficiencies. Assessment of primary fibroblast-derived mRNAs, however, revealed a dominant splicing species that utilized an unsuspected putative donor splice site within exon 9, resulting in predicted early protein termination (p.Arg637Serfs*34). Conclusions—We describe a new splicing ERCC6 defect causal of Cockayne syndrome. The application of exome sequence analysis was integral to diagnosis, given the complexity of phenotypic presentation in affected family members. The novel splicing defect, furthermore, illustrates how a seemingly minor change in the relative strength of a splice site can have significant biological consequences. | en_US |
| dc.identifier.citation | ASLAN, M., AKINCI, A., DERYA GÜMÜŞ, D., ÜNSAL, O., & KARADAĞ, A. (2013). factors effecting platelet activation in children with poorly controlled type 1 diabetes mellşitus. HealthMED, 7(7), 2227–2234. | en_US |
| dc.identifier.endpage | 2234 | en_US |
| dc.identifier.issn | 1840-2291 | |
| dc.identifier.issue | 7 | en_US |
| dc.identifier.startpage | 2227 | en_US |
| dc.identifier.uri | https://hdl.handle.net/11616/7346 | |
| dc.identifier.volume | 7 | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | HealthMED | en_US |
| dc.relation.ispartof | HealthMED | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Factors effecting platelet activation in children with poorly controlled type 1 diabetes mellşitus | en_US |
| dc.type | Article | en_US |
